JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online August 17, 2007, 10.2967/jnumed.107.041699
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.107.041699v1
48/9/1482    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Langen, K.-J.
Right arrow Articles by Zilles, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Langen, K.-J.
Right arrow Articles by Zilles, K.
Journal of Nuclear Medicine Vol. 48 No. 9 1482-1491
© 2007 by Society of Nuclear Medicine

doi: 10.2967/jnumed.107.041699

Basic Science Investigation

Detection of Secondary Thalamic Degeneration After Cortical Infarction Using cis-4-18F-Fluoro- D-Proline

Karl-Josef Langen1,2, Dagmar Salber3, Kurt Hamacher2,4, Gabriele Stoffels3, Guido Reifenberger5, Dirk Pauleit1,2, Heinz H. Coenen3,4 and Karl Zilles1–3,

1 Institute of Neuroscience and Biophysics–Medicine, Research Centre Jülich, Jülich, Germany; 2 Brain Imaging Centre West, Research Centre Jülich, Jülich, Germany; 3 C. & O. Vogt Institute of Brain Research, Heinrich-Heine-University, Düsseldorf, Germany; 4 Institute of Neuroscience and Biophysics–Nuclear Chemistry, Research Centre Jülich, Jülich, Germany; and 5 Department of Neuropathology, Heinrich-Heine-University, Düsseldorf, Germany

Correspondence: For correspondence or reprints contact: Karl-Josef Langen, MD, Institute of Neuroscience and Biophysics–Medicine, Research Centre Jülich, D-52425 Jülich, Germany. E-mail: k.j.langen{at}fz-juelich.de

The amino acid cis-4-18F-fluoro-D-proline (D-cis-18F-FPro) exhibits preferential uptake in the brain compared with its L-isomer, but the clinical potential of the tracer is as yet unkown. In this study we explored the cerebral uptake of D-cis-18F-FPro in rats with focal cortical infarctions. Methods: Focal cortical infarctions were induced in different areas of the cortex of 20 Fisher CDF rats by photothrombosis (PT). At variable time points after PT (1 d to 4 wk), the rats were injected intravenously with D-cis-18F-FPro. For comparison, 12 rats were injected simultaneously with 3H-deoxyglucose (3H-DG), 3 rats were injected with 3H-methyl-L-methionine (3H-MET), and 2 rats were injected with 3H-PK11195. Within 2 h after injection of the tracers, coronal cryosections of the brains were produced and evaluated by dual-tracer autoradiography. Lesion-to-brain ratios (L/B ratios) were calculated by dividing the maximal uptake in areas with increased tracer uptake by the mean uptake in normal brain tissue. Histologic slices were stained by toluidine blue and by immunostainings for glial fibrillary acidic protein (GFAP), CD68 for macrophages, and CD11b for microglia. Results: Prominent uptake of D-cis-18F-FPro was found in ipsilateral thalamic nuclei (TN) and partially in the corpus striatum starting at 3 d after infarction with increasing L/B ratios up to 4 wk (mean L/B ratio ± SD, 6.7 ± 3.5). The involved TN varied with the site of the cortical lesion corresponding to their thalamocortical projections connecting them with their specific target region in the cerebral cortex. The TN were positive for CD11b and GFAP from day 7 onward, whereas uptake of 3H-DG, 3H-MET, and 3H-PK11195 and immunostaining for CD68 were similar to that of normal brain. Furthermore, increased uptake of D-cis-18F-FPro was found in the area of the cortical infarctions (mean L/B ratio ± SD, 12.1 ± 8.1). From day 5 onward, the pattern of uptake was congruent with that of immunostaining for CD11b and CD68 but was different from that of GFAP. Conclusion: D-cis-18F-FPro appears to be a sensitive PET tracer for detection of secondary degeneration of TN after cortical injury. The uptake mechanisms of D-cis-18F-FPro remain to be elucidated, but the relationship to microglial activation suggests a diagnostic potential in various brain diseases.

Key Words: cis-4-18F-fluoro-D-proline • cortical infarction • thalamic degeneration • PET • microglia

COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2007 48: 11A-12A. [Full Text]  






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2007 by the Society of Nuclear Medicine.